ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,162.92
0.24%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Humacyte Inc (HUMAW)

  7. Humacyte Inc (HUMAW) News

Humacyte (HUMAW)

Humacyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HUMAW
DateTimeSourceHeadlineSymbolCompany
13/06/202421:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAWHumacyte Inc
13/06/202421:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
13/06/202421:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
12/06/202421:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
05/06/202400:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
05/06/202400:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
05/06/202400:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAWHumacyte Inc
04/06/202423:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
04/06/202423:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
04/06/202421:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
03/06/202421:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
03/06/202421:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
03/06/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
31/05/202421:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
31/05/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
30/05/202418:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
30/05/202416:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAWHumacyte Inc
21/05/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
21/05/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
20/05/202421:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAWHumacyte Inc
13/05/202421:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAWHumacyte Inc
10/05/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAWHumacyte Inc
 Showing the most relevant articles for your search:NASDAQ:HUMAW

Your Recent History

COIN
SIPHERUST
Sipher Token
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved